However, consistent establishment, decreased estrogen receptor (ER) expression, and loss of ER-dependent transcription after extended culturing continues to be a challenge for the generation and use of organoid models from ER+ breast tumors. This evidence concerns the gene ESR1 and breast neoplasm.